A Dietary Supplement Examined for Anti-ageing Effects

December 2, 2024 updated by: Prenetics Global

A 12-week Randomized Controlled Clinical Trial Evaluating the Efficacy of a Dietary Supplement in an Adult Population.

dietary supplement for healthy ageing

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria: Healthy Adults -

Exclusion Criteria: Diseases deemed to be unable to participate in the study

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental
dietary supplement
Dietary supplement: Longevity pill
vitamins and herbs

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cogntiion
Time Frame: 12 weeks
Memory Test - Mini Mental State Exam where a higher score indicates a better memory
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Prenetics Global

Collaborators

San Francisco Research Institute

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 21, 2024

Primary Completion (Estimated)

February 27, 2025

Study Completion (Estimated)

April 1, 2025

Study Registration Dates

First Submitted

November 4, 2024

First Submitted That Met QC Criteria

December 2, 2024

First Posted (Actual)

December 3, 2024

Study Record Updates

Last Update Posted (Actual)

December 3, 2024

Last Update Submitted That Met QC Criteria

December 2, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • PR20240502

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

de identified data excel spreadheets

IPD Sharing Time Frame

11/21/2024 - 4/15/2025

IPD Sharing Access Criteria

data excel sheets de identified through encrypted email

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ageing Signs

Clinical Trials on Longevity pill

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe